Ranitidine 55111-0131
Product NDC
55111-0131- Manufacturer
- Dr. Reddy's Laboratories Limited
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 1, 2000
- Listing Expires
- December 31, 2026
- Application
- ANDA075294
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranitidine Hydrochloride | 75 mg/1 |
Drug Class
Histamine H2 Receptor Antagonists [MoA]Histamine-2 Receptor Antagonist [EPC]
Packaging Options(10)
1 BOTTLE in 1 CARTON (55111-131-04) / 120 TABLET in 1 BOTTLE
2 BLISTER PACK in 1 CARTON (55111-131-14) / 10 TABLET in 1 BLISTER PACK
1 BOTTLE in 1 CARTON (55111-131-30) / 30 TABLET in 1 BOTTLE
1 BOTTLE in 1 CARTON (55111-131-37) / 160 TABLET in 1 BOTTLE
1 BOTTLE in 1 CARTON (55111-131-45) / 45 TABLET in 1 BOTTLE
1 BOTTLE in 1 CARTON (55111-131-60) / 60 TABLET in 1 BOTTLE
1 BLISTER PACK in 1 CARTON (55111-131-79) / 10 TABLET in 1 BLISTER PACK
1 BOTTLE in 1 CARTON (55111-131-80) / 80 TABLET in 1 BOTTLE
3 BLISTER PACK in 1 CARTON (55111-131-81) / 10 TABLET in 1 BLISTER PACK
1 BOTTLE in 1 CARTON (55111-131-90) / 90 TABLET in 1 BOTTLE